Global Ganja Report

In the most serious challenge yet to Colorado's cannabis legalization policy, the states of Nebraska and Oklahoma took the unusual move of filing a case against it directly with the US Supreme Court. The two states argue that "the State of Colorado has created a dangerous gap in the federal drug control system...  Marijuana flows from this gap into neighboring states, undermining Plaintiff States' own marijuana bans, draining their treasuries, and placing stress on their criminal justice systems." Lawyers for the Cornhusker State and the Sooner State assert that local authorities have registered a big uptick in cannabis entering their towns since Colorado legalized with voter-approved Amendment 64 in 2012. The suit also claims Colorado's legalization policy violates the Supremacy Clause of the US Constitution.

On New Year’s Day, as retail sales of cannabis went legal in Colorado, the state's dispensaries registered well over $1 million in sales. Despite cold and wet weather, most of the 36 shops that opened that day reported long lines, with some customers waiting outdoors for hours. By the end of the first week, by which time another dozen retail outlets had opened, the figure was a whopping $5 million. More than 100 dispensaries in the Centennial State have now received licenses for retail cannabis sales and over 500 are eligible to apply. More are applying every day.

"A new industry is developing in a nascent state in Colorado," says Rachel Gillette, director of the Colorado chapter of the National Organization for the Reform of Marijuana Laws (NORML). "We're not just talking about retail sales, but a lot of other types of business associated with it—construction companies, HVAC contractors, nutrient companies, lighting and equipment sales, packaging, printers, labeling, marketing materials, websites, marijuana tourism, attorneys, payroll companies… This could represent a lot of jobs."

Well, here's some telling news. According to the Colorado Department of Public Health & Environment, cannabis use among Colorado teens has actually dropped slightly since the state legalized recreational use in 2012. Predictably, the bureaucrats did not emphasize these results. The department's Aug. 7 press release stressed another finding from the survey, that showed Colorado teens view cannabis as less risky than they did a few years ago. The release says preliminary results from the 2013 Healthy Kids Colorado Survey show that 54% of teens in the state consider the stuff risky, down from 58% in 2011. "If we want Colorado to be the healthiest state in the nation, then we need to make sure our youngest citizens understand the risks of using potentially harmful substances," said the department's executive director Larry Wolk. It was left to the Washington Examiner to tout the department's other findings—that even if kids view pot as less risky, they are also smoking it less. Kayvan Khalatbari, co-foundet the Denver Relief dispensary, is quoted venturing a plausible explanation: "Cannabis, now that it's legal, kind of is an old person's drug. It's something that kids are seeing adults use all over the place. It just doesn't seem as cool to kids anymore."

The American Herbal Products Association (AHPA) released its long-awaited medical marijuana manufacturing guidelines July 22, completing its compendium of industry standards which include regulatory recommendations for cannabis from seed to sale. The AHPA manufacturing guidelines come as licensed Colorado business At Home Baked sees the country's first medical marijuana product recall. A new nationwide program called Patient Focused Certification (PFC), a project of Americans for Safe Access (ASA), aims to bring greater standardization to the medical marijuana industry. The PFC program uses the recently completed AHPA guidelines in combination with standards set by American Herbal Pharmacopoeia (AHP) for the plant's identity, purity, quality and botanical properties. Together, these standards have the means to bring greater accountability to the industry and increased safety for patients.

Cannabis cultivation is emerging as an issue in the American West's interminable conflicts over control of water. On May 20, the US Bureau of Reclamation (BuRec), which supplies irrigation districts across the western states, issued a policy memo saying its water may not be used for marijuana. BuRec staff would document "all activities and communications" regarding "known or potential uses" of its waters for cannabis cultivation—and "will report such use to the Department of Justice." Washington state's Roza Irrigation District, which supplies BuRec water to some 72,000 acres in Yakima and Benton counties, in early April issued a "precautionary message" warning cannabis growers that they could get cut off.

OK, here comes the latest media blitz in the backlash against the recent gains for cannabis legalization... The Associated Press on May 6 runs a lurid story (one of several suddenly in the news), topped by a photo of a forelorn burn victim petting his dog for comfort, entitled "Hash Oil Explosions Rise With Legalized Marijuana." The incendiary lede: "The opening months of Colorado's first-in-the-nation recreational marijuana industry have seen a rise in fiery explosions and injuries as pot users try to make the drug's intoxicating oil in crude home-based laboratories. Since Jan. 1, when sales began, the state's only certified adult burn center has treated 10 people with serious injuries they suffered while making hash oil, compared with 11 in 2013 and one in 2012." Firefighters in Colorado have responded to at least 31 hash-oil explosions so far this year, compared with 11 all of last year, according to the Rocky Mountain High Intensity Drug Trafficking Area—a slightly questionable claim, given that the number of explosions and number of casualties for last year are identical. A police sargeant in the Denver suburb of Thornton, which saw its first such explosion in January, is quoted: "These today are the meth labs of the '90s."

Drug Enforcement Administration chief Michele Leonhart, in testimony before a House Appropriations subcommittee April 2, went on the offensive against the cannabis legalization initiatives in Washington state and Colorado. "What was explained to the voters was how much money that they'd be raising," Leonhart said. "What was explained to the voters was that this was good for law enforcement, because then police could go after the real crimes. What was told to the voters is that this would collapse the Mexican drug cartels." Instead, Leonhart asserted, Mexican drug cartels are "setting up shop" in Washington and Colorado in anticipation of a cannabis boom. "Whatever the price will be set in Washington and Colorado, criminal organizations are ready to come in and sell cheaper," she said. She also claimed, without offering evidence, that many cannabis shops get their supplies from grow operations controlled by cartels. 

British firm GW Pharmaceuticals has won "orphan drug status"—a special category for agents developed to treat rare diseases—from the US Food and Drug Administration (FDA) for Epidiolex, a derivative of cannabidiol (CBD), to treat Dravet syndrome, a severe form epilepsy. In Utah, parents who are lobbying to import CBD-rich cannabis strains from Colorado, say they will keep up their campaign. "This changes nothing" in regard to children being able to access CBD, said Jennifer May, mother of 11-year-old Stockton, who suffers from Dravet syndrome. "On the other hand, it does lend credibility to the potential of CBD as a treatment." Like many Dravet patients, Stockton has tried dozens of pharmaceutical fixes, and run out of options. He can no longer use the toilet and has to be fed from a tube. "Orphan drug" designation qualifies GW for tax credits and exclusive rights to the drug if approved. But FDA approval for Epidiolex could take a year or more. (Salt Lake Tribune, Nov. 18)